Cargando…
Quantitative evaluation of safety in drug development : design, analysis and reporting /
State-of-the-Art Methods for Drug Safety AssessmentResponding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and obser...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Boca Raton :
Chapman & Hall/CRC,
2014.
|
| Colección: | Chapman & Hall/CRC biostatistics series.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn897882766 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 141125s2014 flua ob 001 0 eng d | ||
| 040 | |a UKMGB |b eng |e pn |c UKMGB |d OCLCO |d OCLCF |d EBLCP |d OCLCQ |d OCLCA |d MERUC |d OCLCQ |d UKMGB |d OCLCQ |d OCLCO |d K6U |d OCLCQ |d OCLCO |d OCLCL | ||
| 015 | |a GBB4D8386 |2 bnb | ||
| 016 | 7 | |a 016965870 |2 Uk | |
| 016 | 7 | |a 016964621 |2 Uk | |
| 019 | |a 896794898 | ||
| 020 | |a 9781466555471 |q (PDF ebook) | ||
| 020 | |a 1466555475 |q (PDF ebook) | ||
| 020 | |z 9781466555457 |q (hbk.) | ||
| 029 | 1 | |a UKMGB |b 016965870 | |
| 035 | |a (OCoLC)897882766 |z (OCoLC)896794898 | ||
| 037 | |a TANDF_272447 |b Ingram Content Group | ||
| 050 | 4 | |a RS57 | |
| 082 | 0 | 4 | |a 615.10727 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Quantitative evaluation of safety in drug development : |b design, analysis and reporting / |c edited by Qi Jiang, H. Amy Xi. |
| 264 | 1 | |a Boca Raton : |b Chapman & Hall/CRC, |c 2014. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 336 | |a still image |b sti |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Chapman & Hall/CRC Biostatistics Series | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a CIP data; item not viewed. | |
| 505 | 0 | |a Front Cover; Contents; Preface; Editors; Contributors; Chapter 1: Incorporating Quantitative Safety Evaluation into Risk Management; Chapter 2: Bayesian Meta-Experimental Design for Evaluating Cardiovascular Risk; Chapter 3: Non-Inferiority Study Design and Analysis for Safety Endpoints; Chapter 4: Program Safety Analysis Plan: An Implementation Guide; Chapter 5: Why a DMC Safety Report Differs from a Safety Section Written at the End of the Trial; Chapter 6: Safety Surveillance and Signal Detection Process; Chapter 7: Bayesian Adaptive Trials for Drug Safety. | |
| 505 | 8 | |a Chapter 8: Observational Safety Study Design, Analysis, and ReportingChapter 9: Emerging Role of Observational Health-Care Data in Pharmacovigilance; Chapter 10: Roadmap for Causal Inference in Safety Analysis; Chapter 11: Safety Graphics; Chapter 12: Bayesian Network Meta-Analysis for Safety Evaluation; Chapter 13: Regulatory Issues in Meta-Analysis of Safety Data; Chapter 14: Bayesian Applications for Drug Safety Evaluation; Chapter 15: Risk-Benefit Assessment Approaches; Chapter 16: Detecting Safety Signals in Subgroups. | |
| 520 | |a State-of-the-Art Methods for Drug Safety AssessmentResponding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book's three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drugs |x Testing. | |
| 650 | 0 | |a Biometry. | |
| 650 | 0 | |a Drug development. | |
| 650 | 2 | |a Biometry | |
| 650 | 6 | |a Médicaments |x Essais cliniques. | |
| 650 | 6 | |a Biométrie. | |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 7 | |a biometrics. |2 aat | |
| 650 | 7 | |a Biometry |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drugs |x Testing |2 fast | |
| 700 | 1 | |a Jiang, Qi |c (Biostatistician), |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjwktvYgcMgRxqwWHmTx9P | |
| 700 | 1 | |a Xi, H. Amy, |e editor. | |
| 758 | |i has work: |a Quantitative evaluation of safety in drug development (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFK7mFkbqrbM3X8kvrGyV3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version |z 9781466555457 |
| 830 | 0 | |a Chapman & Hall/CRC biostatistics series. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1591629 |z Texto completo |
| 936 | |a BATCHLOAD | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL1591629 | ||
| 994 | |a 92 |b IZTAP | ||